Areas of Focus
- Pathogenesis of Diabetes
- Epigenetics of Pancreatic β-Cells
Work Experience
- 2019-present - Nanjing Medical University - Lecturer/Associate Professor
Academic Background & Achievements
- 2013-2018 PhD in Biochemistry and Molecular Biology: Nanjing Medical University
- 2009-2013 Bachelor's in Biotechnology: Nanjing Medical University
Publications
- HRD1, an Important Player in Pancreatic β-Cell Failure and Therapeutic Target for Type 2 Diabetic Mice, Wu T, Zhang S, Xu J, Zhang Y, Sun T, Shao Y, Wang J, Tang W, Chen F*, Han X*, 2020
- Lentinan protects against pancreatic β-cell failure in chronic ethanol consumption-induced diabetic mice via enhancing β-cell antioxidant capacity, Wu T, Wang J, Zhang Y, Shao Y, Li X, Guo Y, Dong W, Wang L, Chen F*, Han X*, 2021
- Calcium Binding Protein S100A16 Expedites Proliferation, Invasion and Epithelial-Mesenchymal Transition Process in Gastric Cancer, You X, Li M, Cai H, Zhang W, Hong Y, Gao W, Liu Y, Liang X, Wu T*, Chen F*, Su D*, 2021
- Epigallocatechin-3-Gallate Inhibits Ethanol-Induced Apoptosis Through Neurod1 Regulating CHOP Expression in Pancreatic β-Cells, Wu T, Xiang J, Shan W, Li M, Zhou W, Han X, Chen F*, 2016
- TIMP-1 and CD82: a promising combined evaluation marker for PDAC, Zhang J#, Wu T#, Zhan S, Qiao N, Zhang X, Zhu Y, Yang N, Sun Y, Zhang Xin, Bleich D, Han X*, 2017
Awards
- 2022: Nanjing Medical University 'Outstanding Young and Middle-aged Teacher Support Program' Outstanding Young Backbone Teacher
- 2021: First Prize in Young Teacher Lecture Competition, School of Basic Medicine, Nanjing Medical University
- 2021: Second Prize in Jiangsu Province University Micro-lecture Teaching Competition
- 2021, 2022: Second Prize in Innovation Research and Experimental Design Forum, School of Basic Medicine, Nanjing Medical University, as a guiding teacher